admin_unodc – Page 2 – APAIC – Asia & Pacific Amphetamine-Type Stimulants Information Centre

UNODC: CND decision on international control of Butonitazene enters into force in June 2024

VIENNA, Austria – June 2024: The decision adopted by the Commission on Narcotic Drugs (CND) during its 67th regular session from 18 to 22

The synthetic drug market in East and Southeast Asia has continued to expand as supply of traditional drugs, such as

Vientiane (Lao PDR), 28 May 2024 – The synthetic drug market in East and Southeast Asia continues to grow at

VIENNA, Austria – May 2024: There is a considerable expansion of new cannabis products, containing delta-9-THC, cannabidiol (known as CBD)

VIENNA, Austria – April 2024: Based on preliminary information from 16 countries, 31 new psychoactive substances (NPS) have been identified

VIENNA, Austria – March 2024: At its 67th regular session from 18 to 22 March 2024, the Commission on Narcotic Drugs

VIENNA, Austria – February 2024: Nitazenes are a group of synthetic opioids that have emerged in recent years. They are

Vienna, Austria – December 2023: Since its establishment in 2013, the UNODC Early Warning Advisory (EWA) on new psychoactive substances (NPS)

Metonitazene is a substance in the nitazenes substance group with potent synthetic opioid effects, similar to fentanyl. In a review

VIENNA, Austria – November 2023: The decision adopted by the Commission on Narcotic Drugs (CND) during its 66th Session, from 13 to 17 March 2023, to